Ranbaxy did its maiden public issue in 1973.
With the government asking the companies to operate with only 50 per cent staff strength, and exports dipping to almost zero, the truck and bus drivers idling at the petrol pump say they hardly have any work now. At a petrol pump on the deserted Bavla-Changodar highway near Ahmedabad in Gujarat, several trucks and buses are neatly parked in a row.
A year marked by more lows than highs for Hindi cinema, here's a recap of the best and worst in 2021.
NRI sentenced for 5 1/2 years for producing fake Viagra
The government is targeting 1,200 technical collaborations between Japanese companies and Indian investors for over Rs 42,000 crore, 200 joint ventures with overseas investors for Rs 14,000 crore, and another Rs 14,000-crore investment from about 50 multinational companies.
The company buys distressed assets across the globe and turns them around to not only add to its books but also its product pipeline and regions.
'Try to get in 30 to 60 minutes of a brisk walk every day, like my grandparents would do in the village -- twice a day they would go for morning walks and they would go after dinner.'
Sun Pharma to retain these in most markets; US could be the exception, where the Ranbaxy name has taken a hit.
The recall is the latest in a series of problems to hit Ranbaxy, which has had all its India factories stopped from sending drugs and ingredients to the United States.
The Gurgaon-headquartered drug maker, set to be acquired by another leading domestic company, Sun Pharmaceutical Industries, reported a consolidated net loss of Rs 186 crore for the quarter ended June.
A key lesson for the pharmaceutical sector in this case is to not downplay the significant impact that regulatory non-compliance can have on operations.
In 2013, Daiichi had launched the arbitration proceedings in Singapore.
A source said the competition watchdog would by next month suggest 'structural remedies' that included selling key drug segments as conditions for clearing the country's largest pharmaceutical industry merger.
About 80 per cent of Sicilian businesses cough up a pizzo, of as much as 350 pounds a month. However, the burgeoning power of Cosa Nostra in Sicily, the Camorra in Naples, the 'Ndrangheta in Calabria and the Sacra Corona Unita in Puglia, has led to the infiltration of bigger businesses as well.
'In the short term, we may see some disruptions due to Covid, but in the medium-to-long term, we should keep an eye on US inflation and 10-year bond yields.'
On January 31, the US Federal Trade Commission cleared the merger.
Ranbaxy Laboratories, India's biggest drugmaker, may lose as much as $140 million of revenue in 2009 after the US drug regulator blocked sale of more than 30 generic medicines and 7 APIs made in two factories of the company, according to analysts.
In yet another setback to the Chinese toy industry, millions of toys made in the country are being withdrawn from the US and Australia as they allegedly contained a chemical which mimics the reaction caused by a date-rape drug and could lead to children slipping into coma. Moose Enterprise of Melbourne, Australia, the manufacturer of the popular toy called Aqua Dots, blamed the reaction on substation by a Chinese factory of toxic glue for a safe glue.
According to a study,it is twice as likely to kill young patients during weekends.
Indira Kannan picks Made in Bangladesh, Greed, Moothon.
As its factories resumed operations after over two-month of grim battle against coronavirus, China is busy tapping into the vast business opportunities of export of key medical goods, specially ventilators and personal protection equipment (PPE), across the world, including India, where both private and government bodies are placing orders for the import of these products.
The Indian Pharmaceutical Alliance has approached regulator for a dialogue to understand the concern raised by it
'Even if Serum Institute and Bharat Biotech were successful in ramping up production overnight, what happens to the capacity after the demand from India is met?' asks Sanjeev Nayyar.
In March, the FDA had issued an import alert, banning formulations and active pharmaceutical ingredients from the factory.
The company has been held responsible for the violation of the Drugs and Cosmetic Act, 1940 and the rules framed in 1945.
And when an inspector asked about the contents of unlabelled vials in the laboratory glassware washing area, a plant worker dumped them down a sink and said the contents could not be determined, according to a July 18 letter from the US Food and Drug Administration to Wockhardt, which makes sterile injectable drugs and various forms of insulin.
A report was positive for the presence of two dead and one live insect, FDA Commissioner Uttam Khobargade said in Mumbai.
A widening probe by US authorities involving top drug companies following complaints of price fixing of generics was a point of worry for the participants, said analysts.
'We are rolling out a vaccine when we don't even have the phase 2 trial results; forget about phase 3 trial results.' 'Why are we playing with people's lives?'
For soccer great Diego Maradona, Cuban revolutionary Fidel Castro was more than a friend and fellow Latin American legend, he was "a second father." Maradona said Castro's death late on Friday hit him like a tennis ball to the chest served by Juan Martin del Potro, the Argentine player he cheered on in the Davis Cup final where he received the news. "I wept uncontrollably," Maradona told reporters on the sidelines of the tennis tournament. "After my father, it's the deepest sorrow I know."
The rap from both the US and UK drug regulators, including the latest one from the latter, has hit the scrip.
Olympic Silver medalist Mirabai Chani's feat is a story of grit, dedication and desire, but it isn't unique. In Manipur, discovers Vaibhav Raghunandan.
Business leaders, among others, ask govt to let go of fiscal target, seek stimulus, and direct cash transfer.
'The promises of netas and babus and new laws, however well-meaning, mean little.' 'What matters is implementation on the ground.' 'Every law is finally implemented by a vast army of offici
The FDA actions eventually led to a $500-million fine for Ranbaxy as well as the effective mothballing of many of its Indian factories.
The hospital, in the commercial hub of Bandra-Kurla Complex, will serve as an isolation facility for non-critical COVID-19 patients. Expected to be ready in a fortnight, the new makeshift facility can be scaled up to 5,000 beds, if needed. The Brihanmumbai Municipal Corporation will run the hospital that will have, among other things, oxygen facilities and pathological laboratories. Sohini Das reports.
Ranbaxy, which is 63.5 per cent-owned by Japan's Daiichi Sankyo Co and gets more than 40 per cent of its sales from the United States, did not immediately respond to a request on Wednesday for comment on the FDA observations.
